Founded in Dallas, Texas, Rapid Therapeutic Science Laboratories focuses on developing innovative aerosol technology for the cannabis and hemp industry. The company's core mission is to provide safe, effective, and high-quality CBD delivery systems. Their flagship product, Rxoid™, offers precise dosing with each actuation, ensuring users receive an exact 5mg of CBD without any hallucinogenic THC or contaminants. Rapid Therapeutic aims to revolutionize the CBD market by combining advanced technology with the highest quality hemp-derived CBD.
Notable figures associated with Rapid Therapeutic include key investors and industry experts who support its mission to enhance CBD delivery methods. The company has achieved significant milestones, such as the successful launch of Rxoid™, which has been praised for its efficacy and safety. Rapid Therapeutic's impact on the market is evident through its commitment to quality and innovation, setting new standards in the cannabis and hemp sectors.